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Abstract
Background: Reactive arthritis (ReA) is a recognized sequela of infectious gastroenteritis (IGE). However, the
population-based incidence of IGE-related ReA is poorly defined, and the risk of disease has not previously been
characterized in a military population. The intent of this study was to provide estimates of the incidence and
morbidity associated with IGE-related ReA in the U.S. military population.
Methods: Using active duty US military medical encounter data from the Defense Medical Surveillance System, we
conducted a matched case-control study to assess the risk of ReA following IGE. Both specific and nonspecific case
definitions were utilized to address ICD-9 coding limitations; these included specific ReA (Reiter’s Disease or
postdysenteric arthritis) and nonspecific arthritis/arthralgia (N.A.A) (which included several related arthropathy and
arthralgia diagnoses). Incidence was estimated using events and the total number of active duty personnel for
each year.
Results: 506 cases of specific ReA were identified in active duty personnel between 1999 and 2007. Another
16,365 cases of N.A.A. were identified. Overall incidence was 4.1 (95% CI: 3.7, 4.5) and 132.0 (95% CI, 130.0-134.0)
per 100,000 for specific ReA and N.A.A, respectively. Compared to the youngest age category, the incidence of
both outcomes increased 7-fold with a concurrent increase in symptom duration for cases over the age of 40.
Specific IGE exposures were documented in 1.4% of subjects. After adjusting for potential confounders, there was a
significant association between IGE and ReA (specific reactive arthritis OR: 4.42, 95% CI: 2.24, 8.73; N.A.A OR: 1.76,
95% CI: 1.49, 2.07).
Conclusions: Reactive arthritis may be more common in military populations than previously described. The
burden of ReA and strong association with antecedent IGE warrants continued IGE prevention efforts.
Background
Although infectious gastroenteritis (IGE) is typically a
short-lived, acute illness, disease morbidity is significant.
Incidence rates in travelers have been reported at 29
episodes per 100 person-months, based on self-reported
symptoms and cohort studies[1]. Total IGE morbidity is
likely underestimated due to unmeasured chronic seque-
lae, including reactive arthritis (ReA)[2-8]. ReA is a sys-
temic inflammatory disorder characterized by an
asymmetric, additive, aseptic arthritis triggered by an
infection at a distant site. Previously considered a self-
limited disease, the potential of ReA to cause prolonged,
recurrent, or erosive disease has increasingly been
recognized[2,3,5,7,9-11].
IGE-associated ReA is most commonly described after
infection with Campylobacter [11-15], Salmonella
[16-19], Shigella[4,20], and Yersinia[21,22]. Other ReA
case reports have implicated asymptomatic enteric infec-
tions[23], enterotoxigenic E. coli (ETEC)[10,24], Cryptos-
poridium spp[25,26], Giardia lamblia[27], Strongyloides
stercoralis[28], and possibly Schistosoma mansoni[23],
and Clostridium difficile[29-33].
Two pseudonyms for ReA exist. Reiter’sd i s e a s e( R D )
refers to the classic triad of arthritis, urethritis, and con-
junctivitis, while postdysenteric arthritis (PA) refers spe-
cifically to IGE-related disease. In recent years, both
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arthritis, although the naming convention has not been
standardized[2,34]. Current ICD-9 coding includes PA
and RD, but not ReA.
Prior studies based on culture-confirmed bacterial dis-
ease have estimated incidence rates of 3.1-5.0 per
100,000[35,36]. However, these estimates do not account
for non-bacterial etiologies or uncultured IGE-associated
ReA. A Scandinavian study showed a higher incidence
(18 per 100,000) based on serologic and/or culture-
based evidence of a prior infection[37].
The US military is at high risk of exposure to IGE-
causing pathogens during deployment [1,38,39] and may
subsequently be at an increased risk of ReA. The con-
siderable health-care associated costs and decreased
quality of life associated with ReA and other IGE seque-
lae could represent an important consideration to
further justify efforts aimed at decreasing the incidence
of IGE among US military.
Methods
This was a matched case-control study to evaluate ReA
associated with IGE in a US military population. Data
were obtained from the Armed Forces Health Surveil-
lance Center (AFHSC) which operates the Defense Med-
ical Surveillance System (DMSS), a database containing
medical data on all active duty US military personnel
[40]. All records meeting outcome case definitions from
1999 to 2007 were included. These data were linked via
social security number to demographic data from the
Defense Manpower Data Center (DMDC), and deploy-
ment data. Data were compiled into a single dataset, de-
identified, and provided to the investigators by AFHSC
personnel. The number of active military personnel,
stratified by service, year, and age, was obtained through
the Defense Medical Epidemiology Database (DMED)
[41]. The study protocol was approved by the Naval
Medical Research Center and the Uniformed Services
University of the Health Sciences Institutional Review
Boards in compliance with all applicable Federal regula-
tions governing the protection of human subjects.
Outcome
The primary outcome of interest was ReA. Cases were
identified using ICD-9 codes associated with ReA that
met case definitions as described in Table 1. Since there
is no ICD-9 code for ‘reactive arthritis’, and because RD
has historically required the presence of cervicitis or
urethritis, several nonspecific arthropathy and arthralgia
related ICD-9 codes were included. Postdysenteric
arthritis and RD cases were combined into a ‘specific
reactive arthritis’ outcome. Cases meeting the nonspeci-
fic definition were termed ‘nonspecific arthropathy/
arthralgia’ (N.A.A). To minimize incorrect or spurious
diagnoses, our case definitions required a minimum of
two separate ReA-related medical encounters within a
12 month period.
ReA cases with a concurrent diagnosis of chlamydia or
gonococcal disease (within 6 months; by ICD-9 code)
were excluded. All other ReA cases were included in the
analysis. Each case was matched by year of birth, sex,
and calendar year to 4 controls with unrelated medical
encounters.
The number and duration of ReA-related clinical visits
were determined using the number of medical encoun-
ters with a ReA-related ICD-9 and time between the
first and last ReA-related visit, respectively. When avail-
able, the affected site was also recorded (Reiter’sd i s e a s e
ICD-9 code 099.3 does not include a sub-code to indi-
cate affected site).
Exposure
The primary exposure of interest was infectious gastro-
enteritis (IGE). Prior surveys have indicated that stool
cultures are requested in less than 50% of outpatient vis-
its for acute diarrhea[42]. As such, exposures were eval-
uated both for specific pathogens, and for nonspecific
infectious enteritis as previously described[43]. Expo-
sures were determined by ICD-9 codes for clinical visits
within a 6-month window prior to case-presentation or
censoring.
Potential confounders
Demographic variables such as race, rank, marital status,
educational level, and branch of service were evaluated
as potential confounders. Deployment to an area of high
traveler’s diarrhea risk within 6 months of censure was
also evaluated as a surrogate for IGE. High-risk deploy-
ments were defined as Operation Iraqi Freedom, Opera-
tion Enduring Freedom, the Persian Gulf, and/or
Southwest Asia.
Analysis
Crude incidence rates were calculated using the number
of incident ReA cases, and active duty population fig-
ures. Confidence intervals for rates were computed
using exact binomial methods. Analysis of change in
incidence rates over time was completed using a Poisson
regression. A Pearson’s Chi-square test was used to
compare the proportion of cases receiving care at given
time-points after initial diagnosis. The association
between ReA, IGE, and potential covariates was assessed
using univariate and multivariate conditional logistic
regression models. For the multivariate models, a back-
wards elimination approach was used and variables were
dichotomized based on univariate analyses. The variable
with the largest p-value was removed, and the model
was then re-fit. This process was continued iteratively
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at an alpha = 0.15. Separate analyses were performed for
the specific ReA diagnosis (RD and PA) and the nonspe-
cific diagnosis. Two-tailed statistical significance was
evaluated using an alpha of 0.05. Statistical analyses
were performed using SAS v. 8.2 for Windows (SAS
Institute, Cary, NC).
Results
Between 1999 and 2007 a total of 506 subjects met the
specific ReA case definition, including 482 with Reiter’s
disease (RD) and 32 with postdysenteric arthritis (PA).
Eight cases met both the RD and PA case definitions.
An additional 16,365 cases met the nonspecific arthritis/
arthalgia (N.A.A) case definition. Incidence rates for
specific ReA and N.A.A were 4.1 (95% CI: 3.7, 4.5) and
132.0 (95% CI: 130.0, 134.0) per 100,000, respectively. A
rising incidence over time of N.A.A was observed (p <
0.0001), while incidence rates for specific ReA remained
stable (Figure 1).
Demographic data for the included study population
are shown in Tables 2 and 3. For RD and PA, cases
were more commonly deployed to a high risk region in
the 6 months pre-censure (7.5% and 9.4%, respectively)
than controls (3.8% and 3.1%, respectively) (p = 0.001
and p = 0.14, respectively). The opposite was true for N.
A . A ,w h e r ec o n t r o l sw e r em o r el i k e l yt oh a v eb e e n
deployed (4.7%) than cases (2.3%) (p < 0.001). Only 1.4%
of all cases had an exposure documented within the pre-
ceding 6 months, and very few of these indicated patho-
gen-specific causes. A greater proportion of RD and PA
cases had a documented exposure (3.5% and 3.1%,
respectively), compared to nonspecific ReA (1.3%) (p <
0.001 and p = 0.4, respectively). However, prior IGE was
more common in all cases than in their matched
controls.
For both specific ReA and N.A.A, incidence rose with
increasing age (Beta = 1.04, p = 0.002 and Beta = 55.68,
p = 0.006, respectively). Distribution of cases by age
category is shown in Figure 2. Nonspecific arthritis/
arthralgia rates increased nearly 10-fold over the age
spectrum, from 39.8 per 100,000 (95%CI 36.1-44.0) in
the < 20 age group, to 349.7 per 100,000 (95%CI 339.5-
360.2) in the > 40 age group. Similar increases were
seen for specific ReA diagnoses, from 0.99 per 100,000
(95%CI 0.52-1.82) in the < 20 age group, to 7.09 per
100,000 (95% CI 5.70 - 8.72) in the > 40 age group.
Unadjusted and adjusted odds ratios (OR) with 95%
confidence intervals (95% CI) are shown in Table 4.
After controlling for deployment, branch of service,
marital status, and rank, ReA cases had higher odds of
documented IGE exposure compared to matched con-
trols for both specific ReA (OR: 4.42; 95% CI: 2.24, 8.73)
and N.A.A (OR: 1.76; 95% CI: 1.49, 2.07).
Table 1 Case definitions for primary outcomes
Category ICD-9 code
(s)
Case Definition
Reiter’s Disease 099.3, 711.1 Minimum of two medical encounters with Reiter’s disease coded within 12 months
-OR-
One medical encounter with Reiter’s disease coded, preceded by at least one encounter with a nonspecific
arthropathy coded within 12 months
Postdysenteric arthritis 711.3 Minimum of two medical encounters with postdysenteric arthritis coded within 12 months
-OR-
One medical encounter with postdysenteric arthritis coded, preceded by at least one encounter with a
nonspecific arthropathy coded within 12 months
Specific ReA diagnosis 099.3, 711.1,
711.3
Meets criteria for Reiter’s Disease OR postdysenteric arthritis
Nonspecific arthropathy/
arthalgia
a
716.4, 716.5,
716.6, 716.9,
719.4
Minimum of two medical encounters with a nonspecific arthropathy coded within 12 months. Subjects
meeting the Reiter’s disease or postdysenteric arthritis definitions were excluded.
a The listed nonspecific arthopathy/arthalgia ICD-9 codes correspond to the following: transient arthropathy (all subgroups), unspecified polyarthropathy or
polyarthritis (all subgroups), unspecified monoarthritis (all subgroups), other specified arthropathy (all subgroups), and unspecified arthropathy (all subgroups)
Figure 1 ReA incidence rate (95%CI) by age, category, and
diagnosis.
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increased risk of specific ReA (OR: 2.07; 95% CI: 1.36,
3.15). However, it was protective against N.A.A (OR:
0.47; 95% CI: 0.41, 0.51). Army service (compared to
other branches of service) was associated with an
increased risk of N.A.A (OR 1.54; 95%CI: 1.49, 1.60).
This association was reversed for specific ReA (OR:
0.77; 95% CI: 0.62, 0.94). Odds ratios for marriage and
enlisted status in the N.A.A group were 1.21 (95% CI:
1.16, 1.27) and 1.66 (95% CI: 1.58, 1.74), respectively.
Neither marital status nor rank were associated with a
change in specific ReA risk.
Duration of ReA symptoms was prolonged after initial
diagnosis. Among specific ReA cases that remained on
active duty, 35.5% (89/251) were still receiving ReA-
related medical care for a minimum of 2 years after
initial presentation (Figure 3). This proportion was
lower (p < 0.001) for the N.A.A cases (1,019/6,380;
16.0%). Increased duration of care was associated with
increasing age for both the specific ReA (Cochran Armi-
tage Trend p < 0.001) and non-specific (p < 0.001)
arthropathy/arthralgia outcomes with the following pro-
portion receiving care at least 2 years after initial diag-
nosis (specific ReA: ≤ 25: 13.5%, > 25 to < 35: 29.2%,
Table 2 Demographic characteristics of US military service members diagnosed with Reiter’s disease and
postdysenteric arthritis between 1999 and 2007 and their matched controls
Category Subcategory Reiter’s Disease
Cases
a
Reiter’s Disease
Controls
Postdysenteric Arthritis
Cases
a
Postdysenteric Arthritis
Controls
N 482 1,928 32 128
Age (mean ± SD) 30.9 ± 8.1 30.9 ± 8.1 32.1 ± 8.61 32.1 ± 8.61
Sex (n; %) Male 436 (90.5) 1,744 (90.5) 24 (75.0) 96 (75.0)
Female 46 (9.5) 184 (9.5) 8 (25.0) 32 (25.0)
Race (n; %) Asian 14 (2.9) 106 (5.5) 1 (3.1) 7 (5.4)
Black 57 (11.8) 340 (17.6) 5 (15.6) 26 (20.3)
Hispanic 34 (7.1) 187 (9.7) 2 (6.3) 16 (12.5)
Indian 6 (1.2) 16 (0.8) 0 (0.0) 1 (0.8)
White 356 (73.9) 1,235 (64.1) 23 (71.9) 71 (55.5)
Other/Unknown 15 (3.1) 44 (2.3) 1 (3.1) 7 (5.5)
Marital Status (n; %) Single 171 (35.5) 713 (37.0) 10 (31.3) 55 (43.0)
Married 280 (58.1) 1,141 (59.1) 20 (62.5) 68 (43.0)
Other/Unknown 31 (6.4) 74 (3.8) 2 (6.3) 5 (3.4)
Service Branch (n; %) Air Force 142 (29.5) 459 (23.8) 14 (43.8) 37 (28.9)
Army 156 (32.4) 729 (37.8) 11 (34.4) 54 (42.2)
Marine 59 (12.2) 241 (12.5) 3 (9.4) 14 (10.9)
Navy 125 (25.9) 499 (25.9) 4 (12.5) 23 (18.0)
Rank (n; %) Enlisted 389 (80.7) 1,554 (80.6) 24 (75.0) 94 (73.4)
Warrant 9 (1.9) 21 (1.1) 0 (0.0) 3 (2.3)
Officer 84 (17.4) 353 (18.3) 8 (25.0) 31 (24.2)
Education level (n; %) High School or equivalent 310 (63.9) 1,240 (64.3) 15 (46.8) 77 (60.2)
Some college 63 (13.1) 218 (11.3) 7 (21.9) 11 (8.6)
Bachelors 57 (11.8) 265 (13.7) 7 (21.9) 20 (15.6)
Post grad 33 (6.8) 152 (7.9) 3 (9.4) 14 (10.9)
Unknown 19 (3.9) 53 (2.7) 0 (0.0) 6 (4.7)
High Risk Deployment
b 6 months 36 (7.5) 74 (3.8) 3 (9.4) 4 (3.1)
(n; %) 5 months 31 (6.4) 59 (3.1) 1 (3.1) 4 (3.1)
4 months 22 (4.6) 49 (2.5) 1 (3.1) 2 (1.6)
3 months 15 (3.1) 37 (1.9) 1 (3.1) 1 (1.6)
Documented Infectious 6 months 17 (3.5) 15 (0.8) 1 (3.1) 2 (1.6)
Gastroenteritis (n; %) 5 months 15 (3.1) 11 (0.6) 1 (3.1) 2 (1.6)
4 months 14 (2.9) 10 (0.5) 1 (3.1) 0 (0.0)
3 months 13 (2.7) 9 (0.5) 1 (3.1) 0 (0.0)
Backround active duty population rates: 85% male; 69%white/19%black/12%other; 35%Army/26%AirForce/26%Navy/13%Marine
a Eight cases overlap case definitions for both Reiter’s disease and postdysenteric arthritis
b Deployment to a region at high risk for travelers’ diarrhea (Iraq, Afghanistan, Persian Gulf or Southwest Asia) within the indicated number of months prior to
ReA diagnosis (cases) or censoring (controls)
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≥35: 58.9%). Males had significantly higher proportion
receiving care for specific ReA at 2 years than did
females (38.7% vs 7.7%, respectively) (Pearson Chi-
Square p = 0.002). This gender effect was not observed
for the N.A.A outcome.
An analysis of the affected site showed that the major-
ity (47%) of cases had no indicated joint. Although cate-
gories are not mutually exclusive, RD (limited to ICD-9
code 711.1) predominately affected the knee (9.8%) or
multiple joints (17.1%). The hand (15.6%), knee (15.6%),
and multiple joints (28.1%) were the most commonly
affected in PA. N.A.A most commonly affected the
shoulder (22.6%), knee (15.3%), and ankle/foot (13.0%),
with only 2.4% coded as multiple joints.
Discussion
We found an incidence of 4.1 per 100,000 persons for
specific ReA in an active duty population. Prior publica-
tions have reported similar population incidence rates of
3-5 per 100,000, for ReA with culture confirmed antece-
dent bacterial IGE[35,36]. However, as clinical
Table 3 Demographic characteristics of US military service members diagnosed with nonspecific arthropathy/
arthralgia between 1999 and 2007 and their matched controls
Category Subcategory Nonspecific
Arthralgia/
Arthropathy Cases
Nonspecific
Arthralgia/
Arthropathy Controls
N 16,365 65,422
Age (mean ± SD) 33.4 ± 8.8 33.4 ± 8.8
Sex
a (n; %) Male 12,979 (79.3) 51,895 (79.3)
Female 3,385 (20.7) 13,523 (20.7)
Race (n; %) Asian 620 (3.8) 2914 (4.5)
Black 3,687 (22.5) 12,256 (18.7)
Hispanic 1,445 (8.8) 6,290 (9.6)
Indian 250 (1.5) 922 (1.4)
White 9,920 (60.6) 41,210 (63.0)
Other/Unknown 443 (2.7) 1,830 (2.8)
Marital Status (n; %) Single 4,407 (26.9) 20,536 (31.4)
Married 10,904 (66.6) 41,398 (63.3)
Other/Unknown 1,054 (6.4) 3488 (5.3)
Service Branch (n; %) Air Force 3,671 (22.4) 17,089 (26.1)
Army 7,865 (48.1) 24,628 (37.6)
Marine 1,016 (6.2) 6,350 (9.7)
Navy 3,813 (23.3) 17,355 (26.5)
Rank
a(n; %) Enlisted 13,782 (84.2) 50,541 (77.2)
Warrant 312 (1.9) 1,106 (1.7)
Officer 2,271 (13.9) 13,775 (21.1)
Education level (n; %) High School or equivalent 10,781 (65.9) 39,195 (59.9)
Some college 2,023 (12.4) 7,563 (11.6)
Bachelors 1,835 (11.2) 9,511 (14.5)
Post grad 1,330 (8.1) 7,204 (11.0)
Unknown 396 (2.4) 1,949 (3.0)
High Risk Deployment
b 6 months 374 (2.3) 3,097 (4.7)
(n; %) 5 months 280 (1.7) 2,571 (3.9)
4 months 182 (1.1) 2,077 (3.2)
3 months 110 (0.7) 1,568 (2.4)
Documented Infectious 6 months 211 (1.3) 472 (0.7)
Gastroenteritis (n; %) 5 months 181 (1.1) 401 (0.6)
4 months 154 (0.9) 332 (0.5)
3 months 123 (0.8) 256 (0.4)
Backround active duty population rates: 85% male; 69%white/19%black/12%other; 35%Army/26%AirForce/26%Navy/13%Marine
a Missing values: Sex (1 case, 4 controls), Rank (1 control)
b Deployment to a region at high risk for travelers’ diarrhea (Iraq, Afghanistan, Persian Gulf or Southwest Asia) within the indicated number of months prior to
ReA diagnosis (cases) or censoring (controls)
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specific diagnoses, both the incident rate we report and
prior published rates for specific ReA likely underesti-
mate the true incidence of IGE-associated ReA.
Prior studies have reported undifferentiated arthritis
in an attempt to describe cases that do not meet the
full diagnostic criteria for RD or PA. Schillerup et al.
reported an incidence of 41 per 100,000 for undifferen-
tiated inflammatory arthritis[44], and Fendler et al.
described a ReA case series in which 59% of patients
presented with a undifferentiated oligoarthritis[45].
Similarly, we used a N.A.A case definition and found
an incidence of 132 per 100,000. Our N.A.A. case defi-
nition is overly sensitive due to limitations associated
with the use of ICD-9 codes. It is very possible that a
proportion of our N.A.A cases are somehow different
than the specific ReA cases. However, our description
of these cases illustrate an upper bound to the inci-
dence of disease to be used in conjunction with the
lower bound obtained from the highly restrictive post-
infectious gastroenteritis and Reiter’s disease case defi-
nitions. We suspect the large difference in incidence
rates indicate there is a lack of clinical recognition of
the reactive nature of at least some arthritis/arthropa-
thy cases. Of note, we found an increasing incidence of
N.A.A cases from 2002 to 2007 with an unknown
etiology. The impact of deployment tempo during this
time frame on N.A.A incidence could not be deter-
mined, as only data on deployment to certain high-risk
areas was obtained.
Figure 2 Incidence of reactive arthritis and nonspecific
arthropathy/arthralgia in active US military personnel 1999 to
2007.
Table 4 Unadjusted and adjusted
a odds ratios (95% confidence intervals) for exposure variables and included
covariates from a conditional logistic regression model evaluating the risk of specific reactive arthritis and non-
specific arthralgia/arthropathy among active duty US military personnel from 1999 to 2007
Model Variable All Specific ReA Nonspecific Arthralgia/Arthropathy
Univariate Prior exposure
b 4.50 (2.30, 8.82) 1.80 (1.53, 2.12)
High risk deployment
c 2.12 (1.40, 3.21) 0.47 (0.42, 0.52)
Army service 0.77 (0.63, 0.95) 1.54 (1.48, 1.59)
Married 0.96 (0.76, 1.22) 1.22 (1.17, 1.27)
Non-white 0.63 (0.50, 0.78) 1.11 (1.07, 1.15)
Enlisted rank 1.04 (0.79, 1.37) 1.68 (1.60, 1.76)
Multivariate Prior exposure
b 4.42 (2.24, 8.73) 1.76 (1.49, 2.07)
High risk deployment
c 2.07 (1.36, 3.15) 0.46 (0.41, 0.51)
Army service 0.77 (0.62, 0.94) 1.54 (1.49, 1.60)
Married 0.97 (0.76, 1.23) 1.21 (1.16, 1.27)
Enlisted rank 1.03 (0.78, 1.36) 1.66 (1.58, 1.74)
a Adjusted for all covariates retained in the final model (prior exposure, high risk deployment, Army service, married, non-white and enlisted rank)
b Defined as an infectious diarrhea diagnosis six months prior to ReA diagnosis (cases) or censoring (controls)
c Defined as deployment to a region at high risk for travelers’ diarrhea (Iraq, Afghanistan, Persian Gulf or Southwest Asia) six months prior to ReA diagnosis
(cases) or censoring (controls)
Figure 3 Duration of reactive arthritis-associated medical care
in active US military personnel 1999 to 2007.
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increased with age. Published descriptions of age in ReA
indicate most cases occur in a young population, gener-
ally less than 40 years of age[2,23]. This description
likely stems from the earliest case reports of ReA, which
largely consisted of STD-related cases. We found no
prior publications reportinga ni n c r e a s i n gi n c i d e n c e
with age. Further evaluation of the incidence of ReA in
an older population would be worthwhile; however our
use of an active duty study population limits our ability
to do so.
As expected, we found increased odds of prior IGE in
ReA cases compared to matched controls, despite the
low rate of documented antecedent gastroenteritis. After
controlling for covariates, the OR for specific ReA was
4.42 (95% CI: 2.24, 8.73). The effect was smaller in the
N.A.A group (OR: 1.76, 95% CI: 1.49, 2.07), though it
remained statistically significant. Our actual number of
documented cases of IGE was very low; however relying
on medical records for documentation of IGE severely
underestimates the true incidence[42]. A prior popula-
tion-based survey indicated less than a quarter of those
with acute diarrheal illness seek medical care[46]. This
is clearly evident in the paucity of documented IGE
exposures in our cases diagnosed with RD and PA, both
of which require a clinical recognition of antecedent GI
disease.
Our cases are not strictly limited to IGE-related ReA.
While we excluded ICD-9 documented Chlamydia and
gonococcal infections, our methods potentially misses
both asymptomatic chlamydial infections and STI cases
diagnosed outside of military data catchment (such as
through a public health department). However, IGE
related disease likely comprises a large proportion of
all reactive arthritis cases, as has been reported pre-
viously[37].
We assessed the effect of deployment to high traveler’s
diarrhea risk regions as a potential surrogate for IGE,
d u et oi n c o m p l e t ed a t ac a p ture in a deployed popula-
tion. We found an increased odds of prior deployment
in those with specific ReA diagnoses. Conversely, there
was a protective effect of deployment for the N.A.A
diagnoses. The etiology of this relative difference is
unclear, but the unique difficulties in capture of deploy-
ment related illness and injury data may account for the
qualitative shift in the effect estimate. More severe inju-
ries may be preferentially captured as those patients
reach higher levels of care where integrated electronic
medical systems are more prevalent. Additionally, stress
injuries such as tendonitis, trauma, etc are commonly
expected when deployed. Patients may be given one of
these more common diagnoses, rather than one of the
nonspecific codes used in our N.A.A. case definition.
Finally, military members with underlying medical
illness may not be deployed resulting in a type of
“healthy worker” effect which might also explain the
lower rate of diagnoses in deployed personnel.
Inherent difference between the specific ReA and N.A.
A group could account for directional differences in
some effect estimates noted above. This is supported by
the difference in concurrent diagnoses for the two case
definitions. Specifically, approximately 13% of the N.A.A
cases were seen for physical therapy, 4% for lumbago,
and 3% for aftercare following surgery. None of these
co-morbid diagnoses were among the top 20 for the
specific ReA cases. Interestingly, functional gastrointest-
inal diagnoses were prevalent in both groups (data not
shown).
Although the original reports of ReA indicated a self-
limited disease, recent publications have described
chronic disease in up to half of cases, especially in the
presence of HLA-B27[9,34,47]. Our data supports the
idea of a more chronic disease, especially among
patients over the age of 35. While we were unable to
assess the symptoms associated with a ReA-related med-
ical encounter, or HLA-B27 status, ReA continued to be
commonly coded as a primary diagnosis up to 7 years
after the initial medical encounter. The chronicity of
this disease has not been well recognized by clinicians.
However, like the functional gastrointestinal postinfec-
tious disorders, the morbidity associated with ReA needs
to be considered by providers and policy makers when
assessing the impact associated with deployment of
countermeasures, in order to mitigate the effects of
acute enteric infections during deployment.
The U.S. active duty military population was used as
the study population. There are several unique quali-
ties of this population that should be considered when
comparing our findings to the general population. The
military population is younger (the average age is
roughly 28) and generally physically fit, yet extensive
physical stressors likely increase the number of muscu-
loskeletal injuries in this population. Military members
may travel extensively to underdeveloped areas of the
world, placing them at increased risk for IGE expo-
sures. In addition, as there is a direct link between
health and duty status, deployment eligibility, and dis-
ability claim eligibility, members may have additional
ICD-9 coded visits to address the administrative
aspects of health issues.
Utilization of a medical encounter database for epide-
miologic studies carries an intrinsic risk of misclassifica-
tion or systemic biases, in addition to those described
specifically above. Multiple studies have demonstrated
inaccuracies in ICD-9 coding[48-50]. As described in
previous publications, we required multiple medical
encounters for the same diagnosis in an attempt to
minimize case misclassification[43,51].
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In summary, we found that ReA was more prevalent
than previously recognized in the U.S. active duty mili-
tary population, especially when non-specific ReA cases
were considered. This represents a significant burden on
the military healthcare system and may be an important
medical condition in returning veterans. Due to the
strong association between IGE and ReA as well as
other post-infectious sequelae, and the high risk of tra-
velers diarrhea among deployed US service members,
efforts aimed at minimizing IGE incidence in DoD per-
sonnel are warranted and support enhancement of cur-
rent primary prevention strategies and development of
novel solutions.
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